These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 10507083)
1. The influence of lymph node counts on the detection of pelvic lymph node metastasis in prostate cancer. Barth PJ; Gerharz EW; Ramaswamy A; Riedmiller H Pathol Res Pract; 1999; 195(9):633-6. PubMed ID: 10507083 [TBL] [Abstract][Full Text] [Related]
2. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. Heidenreich A; Varga Z; Von Knobloch R J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387 [TBL] [Abstract][Full Text] [Related]
3. Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer. Abdollah F; Sun M; Thuret R; Jeldres C; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI Int J Urol; 2012 Jul; 19(7):645-51. PubMed ID: 22416788 [TBL] [Abstract][Full Text] [Related]
4. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only. Steven K; Poulsen AL J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113 [TBL] [Abstract][Full Text] [Related]
5. [Clinical outcome of radical prostatectomy and pelvic lymph node dissection]. Mizutani K; Ono Y; Kato N; Takeda A; Yamada S; Kinukawa T; Hattori R; Sahashi M; Matsuura O; Takeuchi N Hinyokika Kiyo; 1995 Nov; 41(11):867-71. PubMed ID: 8533688 [TBL] [Abstract][Full Text] [Related]
6. Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases. Perry-Keene J; Ferguson P; Samaratunga H; Nacey JN; Delahunt B Histopathology; 2014 Feb; 64(3):399-404. PubMed ID: 24118022 [TBL] [Abstract][Full Text] [Related]
7. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy. Arenas LF; Füllhase C; Boemans P; Fichtner J Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944 [TBL] [Abstract][Full Text] [Related]
8. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer. Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188 [TBL] [Abstract][Full Text] [Related]
9. Pelvic lymph node dissection for prostate cancer: frequency and distribution of nodal metastases in a contemporary radical prostatectomy series. Godoy G; von Bodman C; Chade DC; Dillioglugil O; Eastham JA; Fine SW; Scardino PT; Laudone VP J Urol; 2012 Jun; 187(6):2082-6. PubMed ID: 22498221 [TBL] [Abstract][Full Text] [Related]
10. Implications of prostate micrometastases in pelvic lymph nodes: an archival tissue study. Edelstein RA; Zietman AL; de las Morenas A; Krane RJ; Babayan RK; Dallow KC; Traish A; Moreland RB Urology; 1996 Mar; 47(3):370-5. PubMed ID: 8633404 [TBL] [Abstract][Full Text] [Related]
11. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy. Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707 [TBL] [Abstract][Full Text] [Related]
12. Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy. Briganti A; Chun FK; Salonia A; Gallina A; Zanni G; Scattoni V; Valiquette L; Rigatti P; Montorsi F; Karakiewicz PI Urology; 2007 Jan; 69(1):147-51. PubMed ID: 17270638 [TBL] [Abstract][Full Text] [Related]
13. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer]. Heidenreich A; Ohlmann CH Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337 [TBL] [Abstract][Full Text] [Related]
14. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719 [TBL] [Abstract][Full Text] [Related]
16. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? Bader P; Burkhard FC; Markwalder R; Studer UE J Urol; 2003 Mar; 169(3):849-54. PubMed ID: 12576797 [TBL] [Abstract][Full Text] [Related]
17. Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomy. Hansen J; Budäus L; Spethmann J; Schlomm T; Salomon G; Rink M; Haese A; Steuber T; Heinzer H; Huland H; Graefen M; Michl U Urology; 2012 Oct; 80(4):877-82. PubMed ID: 22950996 [TBL] [Abstract][Full Text] [Related]
19. The impact of robotic surgery on pelvic lymph node dissection during radical prostatectomy for localized prostate cancer: the Brown University early robotic experience. Yates J; Haleblian G; Stein B; Miller B; Renzulli J; Pareek G Can J Urol; 2009 Oct; 16(5):4842-6. PubMed ID: 19796462 [TBL] [Abstract][Full Text] [Related]
20. Percentage of positive biopsies predicts lymph node involvement in men with low-risk prostate cancer undergoing radical prostatectomy and extended pelvic lymphadenectomy. Heidenreich A; Pfister D; Thüer D; Brehmer B BJU Int; 2011 Jan; 107(2):220-5. PubMed ID: 20590538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]